X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (114) 114
male (86) 86
middle aged (69) 69
female (68) 68
aged (52) 52
index medicus (50) 50
oncology (47) 47
adult (46) 46
nuclear medicine (45) 45
medicine & public health (44) 44
imaging / radiology (41) 41
cardiology (36) 36
orthopedics (36) 36
radiology, nuclear medicine & medical imaging (36) 36
octreotide - analogs & derivatives (27) 27
radiopharmaceuticals (26) 26
radionuclide imaging (25) 25
tumors (25) 25
tomography (24) 24
cancer (23) 23
aged, 80 and over (22) 22
animals (21) 21
sensitivity and specificity (21) 21
prostate cancer (19) 19
patients (18) 18
peptides (18) 18
positron-emission tomography - methods (18) 18
indium radioisotopes (17) 17
iodine radioisotopes (17) 17
medical imaging (17) 17
diagnosis (15) 15
radiopharmaceuticals - pharmacokinetics (15) 15
somatostatin (15) 15
tissue distribution (15) 15
positron-emission tomography (14) 14
scintigraphy (14) 14
computed tomography (13) 13
positron emission tomography (13) 13
receptors, somatostatin - metabolism (13) 13
tomography, emission-computed, single-photon (13) 13
pet (12) 12
pet imaging (12) 12
retrospective studies (12) 12
tumor (12) 12
metastasis (11) 11
positron emission (11) 11
radiation therapy (11) 11
rezeptor (11) 11
fluorodeoxyglucose f18 (10) 10
medicine (10) 10
neuroendocrine tumors (10) 10
neuroendocrine tumors - diagnostic imaging (10) 10
pet/ct (10) 10
positron-emission-tomography (10) 10
radioisotopes (10) 10
reproducibility of results (10) 10
octreotide (9) 9
octreotide - pharmacokinetics (9) 9
treatment outcome (9) 9
care and treatment (8) 8
dosimetry (8) 8
krebs (8) 8
liver neoplasms - diagnostic imaging (8) 8
metastases (8) 8
molecular imaging (8) 8
pancreatic neoplasms - metabolism (8) 8
peptides, cyclic - pharmacokinetics (8) 8
prostata (8) 8
prostatic neoplasms - diagnostic imaging (8) 8
research (8) 8
tomography, emission-computed, single-photon - methods (8) 8
tracers (8) 8
antigen (7) 7
atherosclerosis (7) 7
binding (7) 7
clinical neurology (7) 7
diagnostic systems (7) 7
in vitro techniques (7) 7
ligands (7) 7
magnetic resonance imaging (7) 7
mice (7) 7
organometallic compounds (7) 7
pentetic acid - analogs & derivatives (7) 7
positron emission tomography computed tomography (7) 7
prostate (7) 7
somatostatin - analogs & derivatives (7) 7
somatostatin receptor scintigraphy (7) 7
tomography, x-ray computed (7) 7
young adult (7) 7
antigens (6) 6
case-control studies (6) 6
edetic acid - analogs & derivatives (6) 6
endocrine tumors (6) 6
in-vivo (6) 6
lesions (6) 6
liver (6) 6
liver - diagnostic imaging (6) 6
liver neoplasms - secondary (6) 6
localization (6) 6
membran (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 7/2015, Volume 42, Issue 8, pp. 1284 - 1294
To assess the association between PSA levels, PSA kinetics and other factors and a pathological 68Ga-PSMA PET/CT scan in patients with recurrent prostate... 
68 Ga-PSMA PET/CT | Biochemical relapse | Salvage radiotherapy | Medicine & Public Health | Orthopedics | PSA doubling time | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Recurrent prostate cancer | Ga-PSMA PET/CT
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2/2015, Volume 42, Issue 2, pp. 362 - 363
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 06/2011, Volume 52, Issue 6, pp. 856 - 864
The objective of this study was to compare MRI response assessment with metabolic O-(2-F-18-fluoroethyl)-L-tyrosine (F-18-FET) PET response evaluation during... 
F-FET PET response assessment | Recurrent high-grade glioma | MRI response criteria | Antiangiogenic treatment | CRITERIA | BEVACIZUMAB | MRI | antiangiogenic treatment | TUMOR ANGIOGENESIS | F-18-FET PET response assessment | recurrent high-grade glioma | CHEMOTHERAPY | GLIOBLASTOMA | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | TREATMENT RESPONSE | IRINOTECAN | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Predictive Value of Tests | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Positron-Emission Tomography | Tyrosine - analogs & derivatives | Bevacizumab | Antibodies, Monoclonal, Humanized | Astrocytoma - pathology | Treatment Failure | Astrocytoma - drug therapy | Ultrasonography | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Nervous System Diseases - physiopathology | Retrospective Studies | Glioma - surgery | Radiopharmaceuticals | Camptothecin - analogs & derivatives | Postoperative Complications - physiopathology | Camptothecin - therapeutic use | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Magnetic Resonance Imaging | Glioma - diagnostic imaging | Image Processing, Computer-Assisted | Survival Analysis | Nervous System Diseases - etiology | Glioma - drug therapy | Astrocytoma - surgery | Medical imaging | Clinical medicine | Permeability | Vascular endothelial growth factor | Brain cancer | Tumors
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 12/2013, Volume 8, Issue 1, pp. 4659 - 4671
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 10/2016, Volume 43, Issue 11, pp. 2005 - 2013
This study was designed to determine safety, tolerability, and radiation burden of a [68Ga]NODAGA-RGD-PET for imaging integrin αvβ3 expression in patients with... 
[ 68 Ga]NODAGA-RGD | Metabolic stability | Whole-body distribution | Medicine & Public Health | Orthopedics | Oncology | Hepatocellular carcinoma | Nuclear Medicine | Dosimetry | Imaging / Radiology | Cardiology | PET | Ga]NODAGA-RGD | F-18-GALACTO-RGD | POSITRON-EMISSION-TOMOGRAPHY | CANCER-PATIENTS | INTEGRIN | [Ga-68]NODAGA-RGD | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Whole-Body Counting | Humans | Middle Aged | Male | Metabolic Clearance Rate | Integrin alphaVbeta3 - metabolism | Carcinoma, Hepatocellular - diagnostic imaging | Tissue Distribution | Coordination Complexes - pharmacokinetics | Radiation Exposure - analysis | Liver Cirrhosis - diagnostic imaging | Sensitivity and Specificity | Liver Cirrhosis - metabolism | Female | Reproducibility of Results | Radiopharmaceuticals - pharmacokinetics | Molecular Imaging - methods | Positron-Emission Tomography - methods | Radiation Dosage | Organ Specificity | Liver Neoplasms - diagnostic imaging | Peptides, Cyclic - pharmacokinetics | Liver Neoplasms - metabolism | Aged | Carcinoma, Hepatocellular - metabolism | Pets | Metabolites | Tracers (Biology) | Radiation | Hepatoma | Liver cirrhosis | Integrins | Dosimeters | Renal function | Radiochemical analysis | Liver | Radioisotopes | Bladder | Blood | Liver cancer | Computed tomography | Urinary bladder | Intestine | Tomography | Lesions | Background radiation | Radioactivity | Urine | Excretion | Stability | Medical imaging | Invasiveness | Organs | Positron emission | Muscles | Liquid chromatography | Injection | Metabolism | High-performance liquid chromatography | Patients | Radiation dosage | Cirrhosis | Lungs | Tumors | Pharmaceuticals | [68Ga]NODAGA-RGD | Original
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 1/2015, Volume 42, Issue 1, pp. 20 - 24
PET/CT with 68Ga-labelled [DOTA0,Tyr3]-octreotide (68Ga-DOTA-TOC PET/CT) is a routinely used imaging modality for neuroendocrine tumours expressing... 
Nasopharyngeal carcinoma | Molecular imaging | Medicine & Public Health | Orthopedics | Oncology | Epstein-Barr virus | Nuclear Medicine | Imaging / Radiology | Cardiology | Positron emission tomography | Somatostatin receptors | Squamous cell carcinoma | PET imaging | Tracers (Biology) | Health aspects
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 02/2015, Volume 42, Issue 2, p. 362
  Details of a case involving a 69-year-old prostate cancer patient with extensive metastases to the bone (adenocarcinoma, Gleason score 8, PSA 1,239 g/l, at... 
Radiation therapy | Metastasis | Prostate cancer
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 01/2015, Volume 42, Issue 1, p. 20
  PET/CT with ^sup 68^Ga-labelled [DOTA^sup 0^,Tyr^sup 3^]-octreotide (^sup 68^Ga-DOTA-TOC PET/CT) is a routinely used imaging modality for neuroendocrine... 
Positrons | Tomography | Emissions | Cancer
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 07/2015, Volume 42, Issue 8, p. 1284
  To assess the association between PSA levels, PSA kinetics and other factors and a pathological ^sup 68^Ga-PSMA PET/CT scan in patients with recurrent... 
Biochemistry | Kinetics | Radiation therapy | Prostate cancer
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 07/2015, Volume 42, Issue 8, pp. 1284 - 1294
Purpose: To assess the association between PSA levels, PSA kinetics and other factors and a pathological super(68)Ga-PSMA PET/CT scan in patients with... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.